Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any microphthalmia with linear skin defects syndrome in which the cause of the disease is a mutation in the NDUFB11 gene.
Features include always present findings: Asymmetric, linear skin defects; and common findings: Strabismus, Cardiac arrest, Seizure, and Agenesis of corpus callosum and others. 22 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Heart and blood vessels | 5 | Cardiac arrest, Histiocytoid cardiomyopathy, Ventricular tachycardia |
Eyes | 2 | Strabismus, Nystagmus |
Brain and nerves | 2 | Seizure, Global developmental delay |
Muscles | 2 | Low muscle tone (hypotonia), Axial hypotonia |
Skin | 2 | Hyperpigmented streaks, Asymmetric, linear skin defects |
Hormones | 1 | Thyroid C cell hyperplasia |
Growth and development | 1 | Failure to thrive |
Microphthalmia with linear skin defects (MLS) syndrome is characterized by unilateral or bilateral microphthalmia or anophthalmia and/or jagged skin defects on the face and neck . MLS syndrome is usually lethal in males [, , , , , , , , , ]. Phenotypic variability. Inter- and intrafamilial phenotypic variability has been described. The manifestations differ among affected individuals and, although most display the classic phenotype of MLS syndrome, many have only a subset of characteristic features: some show the characteristic skin defects without ocular abnormalities, whereas others have eye abnormalities without skin defects . For example, a female with a normal phenotype except for typical MLS syndrome skin defects had an affected female fetus with anencephaly.
Eye finding...
Source: GeneReviews — "Microphthalmia with Linear Skin Defects Syndrome"
NDUFB11 encodes NADH:ubiquinone oxidoreductase subunit B11 (153 aa). Accessory subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I), that is believed not to be involved in catalysis. Highest expression in Muscle Skeletal (325.4 TPM) and Thyroid (275.3 TPM).
Linear skin defects with multiple congenital anomalies 3 is associated with mutations in the NDUFB11 gene on chromosome X.
NDUFB11 is classified as a druggable target (Enzyme category) with score 0.3.
Microphthalmia with linear skin defects (MLS) syndrome should be suspected in females with one or both major criteria especially in the presence of a family history consistent with X-linked inheritance with male lethality (see , , and ). Almost all individuals with MLS syndrome are female; however, a few affected males, typically with an XX karyotype, have been reported.
Major Criteria
Microphthalmia and/or anophthalmia
Reported in 81% of affected individuals
Can be unilateral or bilateral
Linear skin defects
Reported in 75% of affected individuals
Present at birth
Usually involve the face and neck , although the scalp and occasionally the upper trunk may be involved
Heal with age, leaving minimal residual scarring
The clinical signs observed in ML...
Source: GeneReviews — "Microphthalmia with Linear Skin Defects Syndrome"
Table 2. Disorders to Consider in the Differential Diagnosis of MLS Syndrome
Disorder | Gene(s) | MOI | Clinical Features |
|---|---|---|---|
PORCN | XL | Distinctive skin findings (dermal hypoplasia); Ophthalmologic manifestations | — |
In focal dermal hypoplasia:limb skeletal malformations Incontinentia pigmenti (IP) | IKBKG(NEMO) | XL |
Genetic testing for NDUFB11 is available. Testing is considered confirmatory for diagnosis.
No approved treatments are currently available for linear skin defects with multiple congenital anomalies 3. The disease remains an area of unmet medical need.
To establish the extent of disease and needs in an individual diagnosed with microphthalmia with linear skin lesions (MLS) syndrome, the following evaluations (if not performed as part of the evaluation that led to the diagnosis) are recommended:
Ophthalmologic examination
Dermatologic evaluation for skin lesions
Brain MRI for corpus callosum dysgenesis and other neurologic abnormalities
Developmental assessment, with further evaluation if significant delays are identified
Cardiac evaluation
Hearing evaluation, as hearing loss is observed in 8% of cases
Consideration of abdominal MRI and standard protocols for management of diaphragmatic hernia
Consultation with a clinical geneticist and/or genetic counselor
The following are appropriate:
Under the guidance of an oculoplastics specialist, use of a prosthesis in severe microphthalmia and anophthalmia
Regular care by a dermatologist for individuals with significant skin lesions
Referral to a pediatric neurologist for evaluation and treatment if microcephaly, seizures, and/or other neurologic abnormalities are present
Appropriate developmental therapies and special education as indicated for developmental delay and intellectual disability
Standard care for cardiac concerns and other malformations, when present
Monitoring and follow up with ophthalmologist, dermatologist, pediatric neurologist, and other professionals as needed is appropriate. Affected indi...
Source: GeneReviews — "Microphthalmia with Linear Skin Defects Syndrome"
View trials for linear skin defects with multiple congenital anomalies 3
Monitoring and follow up with ophthalmologist, dermatologist, pediatric neurologist, and other professionals as needed is appropriate. Affected individuals with cardiac concerns should have regular complete evaluation at intervals determined by the cardiologist.
Source: GeneReviews — "Microphthalmia with Linear Skin Defects Syndrome"
Phenotype severity distribution: 1 always present feature, 19 common features.
No clinical trials have been registered for linear skin defects with multiple congenital anomalies 3.
4 publications have been identified in PubMed for linear skin defects with multiple congenital anomalies 3. Research spans Case Report / Case Series (50%), Review / Meta-Analysis (25%), and Epidemiology / Natural History (25%).
D'Alessio AM (2026). [PMID: 42014911](https://pubmed.ncbi.nlm.nih.gov/42014911/). *Eur J Hum Genet*. [Review / Meta-Analysis]
Hara H (2026). [PMID: 41871061](https://pubmed.ncbi.nlm.nih.gov/41871061/). *PLoS One*. [Epidemiology / Natural History]
Zamarro Díaz LÁ (2026). [PMID: 41714141](https://pubmed.ncbi.nlm.nih.gov/41714141/). *Pediatr Dermatol*. [Case Report / Case Series]
Chen K (2025). [PMID: 40464756](https://pubmed.ncbi.nlm.nih.gov/40464756/). *J Dermatolog Treat*. [Case Report / Case Series]
Data assembled from 6 of 12 sources · Last updated Sep 19, 2026, 3:01 PM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Skin lesions; Ocular abnormalities (present in 35% of those w/IP diagnosis)
Verrucous lesions Oculocerebro-cutaneous syndrome (OCCS)(OMIM 164180) | ? | ? | Focal skin defects; Anophthalmia / microphthalmia |
Aicardi syndrome | ? | XL | Microphthalmia; Pigmentary lesions of the skin |
Source: GeneReviews — "Microphthalmia with Linear Skin Defects Syndrome"